DEA Reclassifies Cannabis-Derived Epilepsy Treatment from Schedule I to 5

READ MORE view source

DEA notes that status change is specific only to Epidiolex and does not amend schedule of whole-plant cannabis and CBD.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

Cannabis Culture, Revolutionary Culture, highest-standard journalism and news delivery about cannabis-related politics, activism, growing information, entertainment and more.

Copyright © 2016 Kannavida | SparksCreative

To Top